Skip to main content

Daiichi Sankyo 

Daiichi Sankyo is a publicly listed pharmaceutical company headquartered in Japan. With more than a century of scientific expertise, it researches, develops, manufactures, and commercialises innovative medicines, particularly in oncology and cardiovascular care. The company is known for its antibody-drug conjugate therapies such as Enhertu, and operates globally across multiple regions. Daiichi Sankyo is included in the Forbes Global 2000.

East Asia & Pacific
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
F Non-mature
Just Transition
6.7/100
Nature Benchmark
24.2/100
Social Benchmark
37.5/100
Gender Assessment
32.9/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter